Patents critical component to development of innovative drugs
By Mari Serebrov
Washington Editor
Washington Editor
If Congress wants a healthy biopharma sector that continues to produce innovative therapies to cure the world’s ills, it needs to ensure that those therapies have strong patent protection.
